Spinal Anesthesia Using Lidocaine and Sufentanil and (Transient Neurological Symptoms) TNS

Completed

• Conditions: Transient Neurologic Symptoms

• Registration Number: NCT01283087
• Lead Sponsor: Vestre Viken Ringerike Sykehus

Brief Summary

The purpose of this study is to find out whether patients receiving spinal anesthesia containing lidocaine and sufentanil get transient neurological symptoms.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-01
• Study First Submitted: 2011-01-21
• Study First Submitted QC: 2011-01-24
• Study First Posted: 2011-01-25
• Primary Completion: 2016-05
• Study Completion: 2016-05
• Status Verified: 2017-11
• Last Update Submitted: 2017-11-23
• Last Update Posted: 2017-11-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 168

Inclusion Criteria

• adults over the age of seventeen years

Exclusion Criteria

• patient refuse spinal anesthesia
• spinal anesthesia is contraindicated
• pregnancy
• patient is incapable of giving consent
• diabetes
• neurological disorders
• chronic pain
• chronic use of analgesics
• spinal anesthesia within five days before the actual surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptoms of transient neurological symptoms	5 days

Trial Locations

Locations (2)

Ringerike Sykehus; 🇳🇴 Hønefoss, Norway

Vestre Viken HF Ringerike Sykehus; 🇳🇴 Hønefoss, Norway